AstraZeneca Pharmaceuticals LP v. Secretary United States Department of Health and H, decided by Third Circuit on May 8, 2025, resulted in a defendant win outcome. The Third Circuit reviewed a distric...
Actavis Laboratories Fl, Inc. v. United States, decided by Federal Circuit on March 21, 2025, resulted in a defendant win outcome. The case concerns the interpretation of the "substantially all" limit...